The role of endogenous glucocorticoids in regulating dendritic cell function in vivo

内源性糖皮质激素在体内调节树突状细胞功能的作用

基本信息

  • 批准号:
    G0601183/1
  • 负责人:
  • 金额:
    $ 81.36万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2008
  • 资助国家:
    英国
  • 起止时间:
    2008 至 无数据
  • 项目状态:
    已结题

项目摘要

Vaccines are hugely important in the fight against infections. However, vaccines against many infections are ineffective and we are interested in finding ways to boost their activity. Vaccines may require special immune cells, called dendritic cells, to become activated. Thus, one reason why vaccines may not work is that these cells do not become activated enough. We have found that dendritic cells produce large amounts of steroids and that this may prevent them from becoming activated. The dendritic cells contain an enzyme that produces the steroid. Although these findings are very obvious when we culture dendritic cells in a test tube, it is now very important to work out what role this enzyme has in preventing immune responses following a vaccination. This requires that we perform experiments in mice, in which the gene that makes the enzyme has been ?knocked out?. In this case, we can take a mouse that is normal in every respect other than the fact that it cannot make the enzyme. We predict that responses to vaccination will be much better in mice that lack the enzyme in their dendritic cells. If so, this will be important, because new drugs have been developed that can block the enzyme from working. Thus, it may be possible to give a vaccine and an enzyme-stopping drug at the same time in order to get a better response.
疫苗在对抗感染方面非常重要。然而,针对许多感染的疫苗是无效的,我们有兴趣找到提高其活性的方法。疫苗可能需要特殊的免疫细胞,称为树突状细胞,被激活。因此,疫苗可能不起作用的一个原因是这些细胞没有被充分激活。我们发现树突状细胞产生大量的类固醇,这可能会阻止它们被激活。树突细胞含有一种产生类固醇的酶。虽然当我们在试管中培养树突状细胞时,这些发现是非常明显的,但现在非常重要的是要弄清楚这种酶在预防疫苗接种后的免疫反应中的作用。这就要求我们在小鼠中进行实验,其中产生酶的基因已经被?晕过去了?在这种情况下,我们可以拿一只在各方面都正常的老鼠,除了它不能制造酶的事实。我们预测,在树突细胞中缺乏这种酶的小鼠对疫苗接种的反应会更好。如果是这样的话,这将是重要的,因为已经开发出可以阻止酶工作的新药。因此,有可能同时给予疫苗和酶抑制剂,以获得更好的反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ronjon Chakraverty其他文献

Graft-Versus-Host Disease Induces Immune Dysregulation through Irreversible Damage to Specialized Immune-Interacting Fibroblastic Stromal Cells in Secondary Lymphoid Organs
  • DOI:
    10.1182/blood-2022-167650
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Leolene Carrington;Shovik Bandyopadhyay;Katlyn Lederer;Samantha Kelly;Ashley Vanderbeck;Gloria Jih;Frederick Allen;Daniela Gómez Atria;Anneka Allman;Eric Perkey;Kai Tan;Norbert Pardi;Burkhard Ludewig;Ronjon Chakraverty;Ivan Maillard
  • 通讯作者:
    Ivan Maillard
Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation
  • DOI:
    10.1016/j.jtct.2021.04.020
  • 发表时间:
    2021-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Maria A.V. Marzolini;Andrew J. Wilson;Emilie Sanchez;Ben Carpenter;Ronjon Chakraverty;Rachael Hough;Panos Kottaridis;Emma C. Morris;Kirsty J. Thomson;Karl S. Peggs
  • 通讯作者:
    Karl S. Peggs
Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus study
嵌合抗原受体T细胞(CAR T细胞)疗法患者电子患者报告结局(ePRO)系统的测量指标选择:一项改良的德尔菲共识研究
  • DOI:
    10.1016/j.eclinm.2025.103256
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    10.000
  • 作者:
    Sarah E. Hughes;Foram Khatsuria;Christel McMullan;Karen L. Shaw;Anita Walker;Francesca Kinsella;David Burns;Olalekan L. Aiyegbusi;Elin Haf Davies;John Ansell;Evelyn Chakera;Charles Craddock;Alastair Denniston;Rebecca Lloyd;Paul Ferguson;Ronjon Chakraverty;Melanie Calvert
  • 通讯作者:
    Melanie Calvert
CMV-Specific T-Cell Therapy Improves Immune Reconstitution Following Unrelated Donor HSCT: Results of a Randomized Controlled Trial
  • DOI:
    10.1016/j.bbmt.2013.12.048
  • 发表时间:
    2014-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Frederick Chen;Andrew Peniket;Eleni Tholouli;Adrian Bloor;Ronjon Chakraverty;David Marks;Antonio Pagliuca;Nigel Russell;Kirsty Thomson;Heather Beard;Katy Newton;Mohammad Raeiszadeh;Simon Thomas;Paul Moss;Karl S. Peggs
  • 通讯作者:
    Karl S. Peggs
Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study
  • DOI:
    10.1182/blood-2023-172590
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Robert Zeiser;Domenico Russo;Ron Ram;Shahrukh K Hashmi;Ronjon Chakraverty;Jan Moritz Middeke;Maurizio Musso;Sebastian Giebel;Ant Uzay;Peter Langmuir;Nada Hamad;Xuechan Li;Maanasa Gowda;Tommaso Stefanelli;Stephanie J. Lee;Takanori Teshima;Franco Locatelli
  • 通讯作者:
    Franco Locatelli

Ronjon Chakraverty的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ronjon Chakraverty', 18)}}的其他基金

Phase I study of transfer of effector memory T cells (Tem) following allogeneic stem cell transplantation. Short title- Transfer of Tem (ToTem)
同种异体干细胞移植后效应记忆 T 细胞 (Tem) 转移的 I 期研究。
  • 批准号:
    MR/R025436/1
  • 财政年份:
    2018
  • 资助金额:
    $ 81.36万
  • 项目类别:
    Research Grant

相似国自然基金

利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
  • 批准号:
    82371145
  • 批准年份:
    2023
  • 资助金额:
    46.00 万元
  • 项目类别:
    面上项目
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
淫羊藿苷拮抗内源性甲醛神经毒性的作用及机制研究
  • 批准号:
    81102683
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Regulation of Osteocyte Survival by Fibroblast Growth Factor Signaling Pathways
成纤维细胞生长因子信号通路对骨细胞存活的调节
  • 批准号:
    10391803
  • 财政年份:
    2022
  • 资助金额:
    $ 81.36万
  • 项目类别:
Regulation of Osteocyte Survival by Fibroblast Growth Factor Signaling Pathways
成纤维细胞生长因子信号通路对骨细胞存活的调节
  • 批准号:
    10577758
  • 财政年份:
    2022
  • 资助金额:
    $ 81.36万
  • 项目类别:
The role of endocannabinoids in circadian disruption induced metabolic dysregulation
内源性大麻素在昼夜节律紊乱引起的代谢失调中的作用
  • 批准号:
    10553059
  • 财政年份:
    2019
  • 资助金额:
    $ 81.36万
  • 项目类别:
The role of endocannabinoids in circadian disruption induced metabolic dysregulation
内源性大麻素在昼夜节律紊乱引起的代谢失调中的作用
  • 批准号:
    10161774
  • 财政年份:
    2019
  • 资助金额:
    $ 81.36万
  • 项目类别:
Fear Reversal Learning in Combat-Related PTSD: A Multi-Model fMRI-PET Approach
战斗相关 PTSD 中的恐惧逆转学习:多模型 fMRI-PET 方法
  • 批准号:
    10292414
  • 财政年份:
    2019
  • 资助金额:
    $ 81.36万
  • 项目类别:
Fear Reversal Learning in Combat-Related PTSD: A Multi-Model fMRI-PET Approach
战斗相关 PTSD 中的恐惧逆转学习:多模型 fMRI-PET 方法
  • 批准号:
    10683712
  • 财政年份:
    2019
  • 资助金额:
    $ 81.36万
  • 项目类别:
The role of endocannabinoids in circadian disruption induced metabolic dysregulation
内源性大麻素在昼夜节律紊乱引起的代谢失调中的作用
  • 批准号:
    10542446
  • 财政年份:
    2019
  • 资助金额:
    $ 81.36万
  • 项目类别:
The role of endocannabinoids in circadian disruption induced metabolic dysregulation
内源性大麻素在昼夜节律紊乱引起的代谢失调中的作用
  • 批准号:
    10559978
  • 财政年份:
    2019
  • 资助金额:
    $ 81.36万
  • 项目类别:
Fear Reversal Learning in Combat-Related PTSD: A Multi-Model fMRI-PET Approach
战斗相关 PTSD 中的恐惧逆转学习:多模型 fMRI-PET 方法
  • 批准号:
    10409697
  • 财政年份:
    2019
  • 资助金额:
    $ 81.36万
  • 项目类别:
The role of endocannabinoids in circadian disruption induced metabolic dysregulation
内源性大麻素在昼夜节律紊乱引起的代谢失调中的作用
  • 批准号:
    10304943
  • 财政年份:
    2019
  • 资助金额:
    $ 81.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了